These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 30244062)
1. Clinical and dermoscopic features of cutaneous BAP1-inactivated melanocytic tumors: Results of a multicenter case-control study by the International Dermoscopy Society. Yélamos O; Navarrete-Dechent C; Marchetti MA; Rogers T; Apalla Z; Bahadoran P; Blázquez-Sánchez N; Busam K; Carrera C; Dusza SW; de la Fouchardière A; Ferrara G; Gerami P; Kittler H; Lallas A; Malvehy J; Millán-Cayetano JF; Nelson KC; Quan VL; Puig S; Stevens H; Thomas L; Marghoob AA J Am Acad Dermatol; 2019 Jun; 80(6):1585-1593. PubMed ID: 30244062 [TBL] [Abstract][Full Text] [Related]
2. Histomorphologic spectrum of germline-related and sporadic BAP1-inactivated melanocytic tumors. Garfield EM; Walton KE; Quan VL; VandenBoom T; Zhang B; Kong BY; Isales MC; Panah E; Kim G; Gerami P J Am Acad Dermatol; 2018 Sep; 79(3):525-534. PubMed ID: 29753057 [TBL] [Abstract][Full Text] [Related]
3. BAP1 tumor predisposition syndrome case report: pathological and clinical aspects of BAP1-inactivated melanocytic tumors (BIMTs), including dermoscopy and confocal microscopy. Soares de Sá BC; de Macedo MP; Torrezan GT; Braga JCT; Fidalgo F; Moredo LF; Lellis R; Duprat JP; Carraro DM BMC Cancer; 2019 Nov; 19(1):1077. PubMed ID: 31706282 [TBL] [Abstract][Full Text] [Related]
4. The morphologic spectrum of germline-mutated BAP1-inactivated melanocytic tumors includes lesions with conventional nevic melanocytes: A case report and review of literature. Wysozan TR; Khelifa S; Turchan K; Alomari AK J Cutan Pathol; 2019 Nov; 46(11):852-857. PubMed ID: 31206729 [TBL] [Abstract][Full Text] [Related]
6. Germline BRCA1-associated protein 1 mutation presenting as BAP1 inactivated melanocytic nevi in a child of a father with fatal paraganglioma. Watchorn RE; Calonje E; Taibjee SM Pediatr Dermatol; 2018 Sep; 35(5):e316-e318. PubMed ID: 29974497 [TBL] [Abstract][Full Text] [Related]
7. Novel insights into the BAP1-inactivated melanocytic tumor. Donati M; Martinek P; Steiner P; Grossmann P; Vanecek T; Kastnerova L; Kolm I; Baneckova M; Donati P; Kletskaya I; Kalmykova A; Feit J; Blasch P; Szilagyi D; Baldi A; Persichetti P; Crescenzi A; Michal M; Kazakov DV Mod Pathol; 2022 May; 35(5):664-675. PubMed ID: 34857909 [TBL] [Abstract][Full Text] [Related]
8. BAP1-inactivated melanocytic tumors show prominent centrosome amplification and associated loss of primary cilia. Ye J; Sheahon KM; LeBoit PE; McCalmont TH; Lang UE J Cutan Pathol; 2021 Nov; 48(11):1353-1360. PubMed ID: 34085298 [TBL] [Abstract][Full Text] [Related]
9. Clinical, dermoscopic, histological and molecular analysis of BAP1-inactivated melanocytic naevus/tumour in two familial cases of BAP1 syndrome. Moawad S; Reigneau M; de la Fouchardière A; Soufir N; Schmutz JL; Granel-Brocard F; Phan A; Bursztejn AC Br J Dermatol; 2018 Oct; 179(4):973-975. PubMed ID: 29754391 [No Abstract] [Full Text] [Related]
10. BAP1-inactivated melanocytic tumor with preserved BAP1 expression? Morphology to the rescue! Duncan LM; Tetzlaff MT J Cutan Pathol; 2020 May; 47(5):459-461. PubMed ID: 32096236 [TBL] [Abstract][Full Text] [Related]
11. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome. Marušić Z; Buljan M; Busam KJ J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915 [TBL] [Abstract][Full Text] [Related]
12. Multiple epithelioid Spitz nevi or tumors with loss of BAP1 expression: a clue to a hereditary tumor syndrome. Busam KJ; Wanna M; Wiesner T JAMA Dermatol; 2013 Mar; 149(3):335-9. PubMed ID: 23552620 [TBL] [Abstract][Full Text] [Related]
13. BAP1-inactivated melanocytic tumour with borderline histopathological features (BAP1-inactivated melanocytoma): A case report and a reappraisal. Ferrara G; Mariani MP; Auriemma M Australas J Dermatol; 2021 Feb; 62(1):e88-e91. PubMed ID: 33107024 [TBL] [Abstract][Full Text] [Related]
14. Histologically Diverse BAP1-Deficient Melanocytic Tumors in a Patient With BAP1 Tumor Predisposition Syndrome. Louw A; Creaney J; Thomas A; Van Vliet C; Harvey NT; Wood BA; Mesbah Ardakani N Am J Dermatopathol; 2020 Nov; 42(11):872-875. PubMed ID: 32649346 [TBL] [Abstract][Full Text] [Related]
15. RAF1 Gene Fusions as a Possible Driver Mechanism in Rare BAP1-Inactivated Melanocytic Tumors: A Report of 2 Cases. Donati M; Martinek P; Kastnerova L; Persichetti P; Michal M; Kazakov DV Am J Dermatopathol; 2020 Dec; 42(12):961-966. PubMed ID: 32769548 [TBL] [Abstract][Full Text] [Related]
17. BAP1-Inactivated Melanoma Arising From BAP1-Inactivated Melanocytic Tumor in a Patient With BAP1 Germline Mutation: A Case Report and Review of the Literature. Donati M; Šteiner P; Kazakov DV Am J Dermatopathol; 2023 Feb; 45(2):117-122. PubMed ID: 36669076 [TBL] [Abstract][Full Text] [Related]
18. Clinical and Histopathologic Characteristics of Melanocytic Lesions on the Volar Skin Without Typical Dermoscopic Patterns. Mikoshiba Y; Minagawa A; Koga H; Yokokawa Y; Uhara H; Okuyama R JAMA Dermatol; 2019 May; 155(5):578-584. PubMed ID: 30865233 [TBL] [Abstract][Full Text] [Related]
19. Gene of the month: BAP1. Wang A; Papneja A; Hyrcza M; Al-Habeeb A; Ghazarian D J Clin Pathol; 2016 Sep; 69(9):750-3. PubMed ID: 27235536 [TBL] [Abstract][Full Text] [Related]
20. Clinical and dermoscopic characteristics of congenital and noncongenital nevus-associated melanomas. Zalaudek I; Conforti C; Guarneri F; Vezzoni R; Deinlein T; Hofmann-Wellenhof R; Longo C; Moscarella E; Kittler H; Argenziano G; Giuffrida R J Am Acad Dermatol; 2020 Oct; 83(4):1080-1087. PubMed ID: 32360715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]